About Twinstrand - Twinstrand is a private clinical-stage biopharmaceutical company dedicated to the discovery and development of biological drugs for the treatment of life threatening diseases. Established in 1995, the company has offices and laboratories in Burnaby, British Columbia, Canada. Twinstrand's platform is based on a unique 'prodrug' targeting concept that is able to descriminate between healthy and diseased cells by the differential expression of certain proteases in these tissues. Research is currently focused on the development of drugs for the treatment of cancer. In addition, the Company has ownership of a platform with broad potential in the treatment of diseases including, but not limited to; hepatitis C, HIV/AIDS, hepatitis A, cytomegalovirus, parasitic infections such as malaria and schistosomiasis, and fungal diseases.
View Top Employees from Twinstrand TherapeuticsWebsite | http://www.twinstrand.com |
Employees | View employees |
Founded | 1995 |
Address | Ste 309 267 West Esplanade, Vancouver, British Columbia V7M 1A5, CA |
Phone | (604) 415-7180 |
Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Health Care, Information Technology, Medical |
Competitors | Cancer Prevention Pharmaceuticals, Inc, Lumos Pharma, Oxford BioTherapeutics, Patrys Limited, Precision Biologics |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Twinstrand Therapeutics employee's phone or email?
Twinstrand Therapeutics is based in Vancouver, British Columbia.
The NAICS codes for Twinstrand Therapeutics are [325, 32, 32541, 3254].
The SIC codes for Twinstrand Therapeutics are [28, 283].